From: Onclive <edigest@onclive.com>
Sent: <Variable Day of week, Month day, 2020 Time AM or PM>
To: <Variable attendee email address>
Subject: Live Broadcast Registration Confirmation
|
|
|
|
Dear [Full Name]
We are pleased to confirm your registration to view this Live Broadcast on a new treatment option for relapsed or
refractory multiple myeloma and diffuse large B‑cell lymphoma.
Thank you for your participation!
|
|
|
[Speaker 1 - Full Name, Credentials]
[Affiliation name]
[City, State /Country]
|
|
|
[Speaker 2 - Full Name, Credentials]
[Affiliation name]
[City, State /Country]
|
|
|
|
|
|
This Live Broadcast is sponsored by Karyopharm
Therapeutics Inc.
© 2020 Karyopharm Therapeutics Inc. All rights reserved.
US-XPOV-XX/20-XXXXX
|
|
|
Onclive – an MJH Life Sciences brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive, Suite 100
Cranbury, NJ 08512
Preferences | Unsubscribe
|
|
|